arrow
S

Stephen J. Greene

Duke University Medical Center
H指数:65
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temporal Trends and Socio-Demographic Disparities in Substance-Related Conditions and Coronary Artery Disease Mortality in U.S adults, 1999–2020

1999-2020年美国成人中物质相关状况与冠状动脉疾病死亡率的时间趋势及社会人口统计学差异

2026-10-020
OAAI
Temporal Trends and Future Projections of P ulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

1968-2040年美国肺栓塞的时序趋势与未来预测及其主要死亡原因:来自CDC WONDER数据库的见解

2026-05-010
PRE
Lipid-lowering Therapies to Target Cardiac Allograft Vasculopathy After Heart Transplantation: Current Evidence and Future Directions

降脂疗法靶向心脏移植后心脏移植血管病:当前证据和未来方向

2025-12-040
PRE
Clinical Outcomes and Healthcare Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG–HF

心力衰竭和甲状腺素转运蛋白淀粉样变性心肌病患者住院的临床结局与医疗成本:GWTG–HF研究的结果

2025-11-080
PRE
A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods

一项实用性试验评估用于指南指导的心力衰竭管理的Anumana临床决策支持工具(ACT-HF)的影响:临床试验设计与方法

2025-11-010
OAAI
Worsening versus advanced heart failure: Management and challenges

恶化与进展性心力衰竭:管理与挑战

2025-10-040
OAAI
Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry

心力衰竭伴高血钾风险患者管理:CARE-HK in HF登记研究

2025-08-110
OAAI
Remote Optimization of Guideline-Directed Medical Therapy Using Home Monitoring in Heart Failure: The GOALS-HF Study

利用家庭监测对心力衰竭患者进行指南指导的医疗治疗远程优化:GOALS-HF 研究

2025-05-200
PRE